Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic use of medicinal cannabis in difficult to manage epilepsy.

Literature DB >> 30088286

Therapeutic use of medicinal cannabis in difficult to manage epilepsy.

John A Lawson¹, Ingrid E Scheffer².

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2018 PMID： 30088286 PMCID： PMC6177700 DOI： 10.1111/bcp.13711

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

21 in total

Review 1. Therapeutic use of medicinal cannabis in difficult to manage epilepsy.

Authors: John A Lawson; Ingrid E Scheffer
Journal: Br J Clin Pharmacol Date: 2018-09-05 Impact factor: 4.335

2. Cannabis for paediatric epilepsy: challenges and conundrums.

Authors: Kerrie-Anne Chen; Michelle A Farrar; Michael Cardamone; John A Lawson
Journal: Med J Aust Date: 2018-02-19 Impact factor: 7.738

Review 3. Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America.

Authors: Ran Abuhasira; Liat Shbiro; Yuval Landschaft
Journal: Eur J Intern Med Date: 2018-01-10 Impact factor: 4.487

4. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

Authors: Orrin Devinsky; J Helen Cross; Linda Laux; Eric Marsh; Ian Miller; Rima Nabbout; Ingrid E Scheffer; Elizabeth A Thiele; Stephen Wright
Journal: N Engl J Med Date: 2017-05-25 Impact factor: 91.245

5. Interactions between cannabidiol and commonly used antiepileptic drugs.

Authors: Tyler E Gaston; E Martina Bebin; Gary R Cutter; Yuliang Liu; Jerzy P Szaflarski
Journal: Epilepsia Date: 2017-08-06 Impact factor: 5.864

6. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.

Authors: Orrin Devinsky; Eric Marsh; Daniel Friedman; Elizabeth Thiele; Linda Laux; Joseph Sullivan; Ian Miller; Robert Flamini; Angus Wilfong; Francis Filloux; Matthew Wong; Nicole Tilton; Patricia Bruno; Judith Bluvstein; Julie Hedlund; Rebecca Kamens; Jane Maclean; Srishti Nangia; Nilika Shah Singhal; Carey A Wilson; Anup Patel; Maria Roberta Cilio
Journal: Lancet Neurol Date: 2015-12-24 Impact factor: 44.182

Review 7. Can we make cannabis safer?

Authors: Amir Englund; Tom P Freeman; Robin M Murray; Philip McGuire
Journal: Lancet Psychiatry Date: 2017-03-02 Impact factor: 27.083

Therapeutic use of medicinal cannabis in difficult to manage epilepsy.

Review 1. Therapeutic use of medicinal cannabis in difficult to manage epilepsy.

2. Cannabis for paediatric epilepsy: challenges and conundrums.

Review 3. Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America.

4. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

5. Interactions between cannabidiol and commonly used antiepileptic drugs.

6. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.

Review 7. Can we make cannabis safer?

Review 8. Adverse health effects of marijuana use.

9. A validation of the new definition of drug-resistant epilepsy by the International League Against Epilepsy.

10. Developmental Effects of Cannabidiol and Δ9-Tetrahydrocannabinol in Zebrafish.

Review 1. Therapeutic use of medicinal cannabis in difficult to manage epilepsy.

2. Care and concern with cannabinoids used therapeutically.

3. Parasitic pharmacology: A plausible mechanism of action for cannabidiol.